As I read the newspapers and listen to television coverage, I am struck by the obsessive focus on weight loss. You simply can't escape it. The marketing of weight-loss drugs, including GLP-1 medications such as Wegovy, Zepbound, Ozempic, and Mounjaro, typically relies heavily on disease-awareness campaigns rather than direct product advertising, primarily because of strict rules governing prescription-drug advertising. Pharmaceutical companies have therefore worked to shift the perception of obesity from a cosmetic concern to a treatable medical condition, while telehealth platforms promote complementary lifestyle solutions.
An especially interesting aspect is the marketing of GLP-1 medications to older women (ages 50 and older). Rather than emphasizing superficial standards of thinness, these campaigns increasingly focus on functional health, vitality, and longevity. They address age-related physiological changes, including metabolic changes associated with menopause, while emphasizing the preservation of mobility, independence, and overall quality of life.
GLP-1 medications treat a range of conditions beyond diabetes and obesity and can improve metabolic health by helping regulate insulin and blood sugar while promoting weight loss. Studies from NIH and the American Heart Association also suggest that these medications provide broader benefits for cardiovascular, liver, and kidney health.
The Risks Marketing Leaves Out
Unfortunately, marketing for these drugs does not always make clear that certain risks may be greater for older women. One concern is that rapid weight loss can be accompanied by a decline in bone density and raise the risk of osteoporosis. Loss of muscle mass and strength can make daily activities, such as climbing stairs or getting up from a chair, more difficult and may increase the risk of falls, fractures, and frailty. Postmenopausal women are already at increased risk for osteoporosis because declining estrogen levels accelerate bone loss. Significant calorie restriction and rapid weight loss may further compromise bone health, potentially increasing fracture risk.
Older women may also be more vulnerable to gastrointestinal side effects, including nausea, vomiting, and constipation, which can easily contribute to dehydration or inadequate nutrition. Because the sensation of thirst often diminishes with age, dehydration can become a serious concern. GLP-1 medications also suppress appetite, making adequate protein intake especially important for preserving muscle mass and supporting healthy aging. In addition, older women are more likely to take multiple medications for conditions such as high blood pressure, high cholesterol, or thyroid disorders. This makes medication management vital as GLP-1 drugs slow gastric emptying and can potentially affect the absorption or timing of oral medications.
The Potential Benefits
The news, however, is not entirely negative when it comes to GLP-1 medications for aging women. There are also potential benefits. Menopause often shifts fat storage toward the abdomen, increasing cardiometabolic risk. GLP-1s can reduce visceral fat and improve insulin sensitivity and blood lipid profiles. Clinical data also indicate reductions in cardiovascular events, including heart attack and stroke, as well as decreases in systemic inflammation, benefits that become important after menopause. Emerging research from the Mayo Clinic is also exploring whether combining GLP-1 medications with hormone therapy could improve overall symptom management, enhance weight-loss outcomes, and help protect muscle mass.
The goal should not simply be a lower number on the scale, but preserving strength, mobility, bone health, and quality of life as we age.
The Takeaway
The takeaway for older women considering GLP-1 medications is that protecting overall health should be just as important as achieving weight loss. Speak to your health care provider about adequate protein intake to preserve muscle mass, how often to include resistance training in a regular exercise routine, and how to monitor bone health, which may include a bone-density screening. Staying well hydrated and maintaining adequate nutrition is essential. Ultimately, the goal should not simply be a lower number on the scale, but preserving strength, mobility, bone health, and quality of life as we age.
About the Author
Bonnie Ohri is Incoming Board President of IAWH Health.
This article is for general education and is not medical advice. Talk with your health care provider before starting, stopping, or changing any medication.